Stem cell-derived exosomes as therapeutic approach for neurodegenerative disorders: from biology to biotechnology


Butantan affiliation
Publication type
Article
Access rights
Open Access
Appears in Collections:
Metrics
Abstract
The aging population has contributed to the rapid rise in the global incidence of neurodegenerative diseases. Despite the medical advances, there are no effective treatments for these disorders. Therefore, there is an urgent need for new treatments for these diseases. In this sense, cell therapy has been recognized as the best candidate for treating incurable diseases, such as neurodegenerative disorders. However, the therapeutic use of these cells can be limited by several factors. Thus, there has been a rediscovery that extracellular vesicles, including exosomes, can be alternatively explored in the treatment of these diseases, overcoming the limits of cell-based therapy. In this sense, this review aims to revisit all areas from biology, including biogenesis and the content of exosomes, to biotechnology, proposing the minimal information required to isolate, characterize, and study the content of these vesicles for scientific and/or clinical purposes.
Reference
Araldi RP, D’Amélio F, Barros HV, Melo TC, Kerkis I. Stem cell-derived exosomes as therapeutic approach for neurodegenerative disorders: from biology to biotechnology. Cells. 2020 Dec;9(12):2663. doi:10.3390/cells9122663.
Link to cite this reference
https://repositorio.butantan.gov.br/handle/butantan/3415
Journal title
Issue Date
2020


Files in This Item:

10.3390cells9122663.pdf
Description:
Size: 1.4 MB
Format: Adobe PDF
View/Open
Show full item record

The access to the publications deposited in this repository respects the licenses from journals and publishers.